Semaglutide Helps Prevent Kidney Damage in People with Obesity

ATTENTION ALL CUSTOMERS:
Due to a recent change in our pharmacy software system, the process for submitting refill requests online has now changed.
Our previous mobile app and your current login credentials will no longer work.
Please click the Refill Prescriptions tab to begin the new process.
Thank you for your patience during this transition.

Now offering hormone and vitality management consults!
Call 706-886-3119 for more information.

Posted October 29, 2024

A new study finds semaglutide, the active ingredient in Ozempic and Wegovy, reduced kidney damage by up to 52% in people with obesity.

Health News is provided as a service to Maddox Drugs site users by HealthDay. Maddox Drugs nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.

Get Healthy!